A trial of adjuvant therapy in colorectal cancer: the VICTOR trial.

A trial of adjuvant therapy in colorectal cancer: the VICTOR trial.

Bibliographic Details
Main Authors:	Pendlebury, S, Duchesne, F, Reed, K, Smith, J, Kerr, D
Format:	Journal article
Language:	English
Published:	Elsevier 2003

Similar Items

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
by: Midgley, R, et al.
Published: (2010)

Adjuvant therapy of colorectal cancer.
by: Midgley, R, et al.
Published: (2000)

VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection
by: Kerr, D, et al.
Published: (2008)

ABC of colorectal cancer: adjuvant therapy.
by: Midgley, R, et al.
Published: (2000)

VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION
by: Midgley, R, et al.
Published: (2008)

Adjuvant chemotherapy for colorectal cancer.
by: Kerr, D, et al.
Published: (1996)

Statistical Considerations for Trials in Adjuvant Treatment of Colorectal Cancer
by: Everardo Delforge Saad, et al.
Published: (2020-11-01)

COX-2 INHIBITION IN THE ADJUVANT SETTING FOR COLORECTAL CANCER
by: Kerr, D
Published: (2010)

Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
by: Midgley, R, et al.
Published: (2005)

Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
by: Kerr, D, et al.
Published: (2000)

Immunotherapy for colorectal cancer: Potential application in an adjuvant setting
by: Kerr, D, et al.
Published: (2000)

New approaches for the treatment of colorectal cancer in the adjuvant setting
by: Kerr, D, et al.
Published: (2004)

Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS)
by: Miller, R, et al.
Published: (2003)

Immunotherapy for colorectal cancer: a challenge to clinical trial design.
by: Midgley, R, et al.
Published: (2000)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
by: Midgley, R, et al.
Published: (2005)

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
by: Love, S, et al.
Published: (2016)

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
by: Kerr, R, et al.
Published: (2016)

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
by: Iveson, T, et al.
Published: (2018)

Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.
by: Sabharwal, A, et al.
Published: (2007)

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.
by: Kerr, D, et al.
Published: (2007)

Capecitabine/irinotecan in colorectal cancer: European early-phase data and planned trials.
by: Kerr, D
Published: (2002)

Victors write the rules: Hypocrisies and legacies of the Nuremberg Trials
by: Jonathan Jackson
Published: (2021-09-01)

Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms.
by: Chia, W, et al.
Published: (2012)

Dietary Polyphenols: Promising Adjuvants for Colorectal Cancer Therapies
by: Laura Bracci, et al.
Published: (2021-09-01)

Aspirin as adjuvant therapy for colorectal cancer - Reinterpreting paradigms
by: Chia, W, et al.
Published: (2012)

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.
by: Huijbers, A, et al.
Published: (2013)

Gene therapy for colorectal cancer.
by: Kerr, D, et al.
Published: (2003)

What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
by: Johnstone, E, et al.
Published: (2008)

Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
by: Kiyoshi Hasegawa, et al.
Published: (2016-01-01)

Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors
by: Cascinu, S, et al.
Published: (2003)

Are NSAIDs Coming Back to Colorectal Cancer Therapy or Not?
by: Herbert, K, et al.
Published: (2014)

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
by: Gray, R, et al.
Published: (2007)

Colorectal cancer in the elderly patient: the role of neo-adjuvant therapy
by: Dodaro Concetta Anna, et al.
Published: (2019-08-01)

CAPECITABINE (CAPE) +/- BEVACIZUMAB (BEV) IN THE ADJUVANT TREATMENT OF COLORECTAL CANCER (CRC) FIRST AND FINAL TOXICITY RESULTS FROM THE INTERNATIONAL PHASE III QUASAR2 TRIAL
by: Midgley, R, et al.
Published: (2012)

Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials
by: Catherine Abrial, et al.
Published: (2009-07-01)

Clinical development of gene therapy for colorectal cancer.
by: Kerr, D
Published: (2003)

A comparison of cancer vaccine adjuvants in clinical trials
by: Morgan Marriott, et al.
Published: (2023-01-01)

ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)
by: Laura Masfarré, et al.
Published: (2021-06-01)

Recurrence‐free survival dynamics following adjuvant chemotherapy for resected colorectal cancer: A systematic review of randomized controlled trials
by: Emma Vail, et al.
Published: (2024-01-01)

Colorectal cancer. Limitations of trial.
by: Peto, R
Published: (2009)